Trial site
Penn Medicine: University of Pennsylvania Health System
- 13running trials
- 1closed trial
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Depression2 trials
- Thalassaemia2 trials
- Alzheimer disease1 trial
- Amyloidosis1 trial
- Bipolar disorder1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Myelodysplastic syndromes1 trial
- Prostate cancer1 trial
- Sickle cell disease1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting7 trials
- Active, not recruiting6 trials
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company8 trials
- Agios Pharmaceuticals, Inc.3 trials
- Celgene1 trial
- Novo Nordisk A/S1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Recruiting
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Recruiting
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression2 recruiting
- Amyloidosis1 recruiting
- Bipolar disorder1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026